• Kinross Gold Corporation on its recently announced plans to acquire Chulbatkan, a high-quality, heap leach development project in Russia, from N-Mining Limited for a total fixed consideration of US$283 million. The deal, which required extensive due diligence of the subsoil license holding company, includes approximately US$113 million in cash and US$170 million in Kinross stock, plus 1.5% contingency payments. The acquisition is a strategic addition to Kinross’s existing mining operations, as it is expected to be a high yield, yet low-cost operation.
    • Daimler AG on its US$250 million acquisition of a 10% stake in Russian truck manufacturer KamAZ, which involved a rapid and comprehensive due diligence of approximately 150 companies.
    • A hedge fund on its acquisition of a significant minority stake in a Russian mining company.
    • OAO Mechel, via its wholly owned subsidiary Oriel Resources, on its US$425 million disposal of the Voskhod Mining Plant (in Khromtau, Kazakhstan) and Tikhvin Ferroalloy Plant (in Tikhvin, Leningrad Region, Russia) to Turkey’s Yildirim Group.
    • Kinross Gold Corporation on its US$3.1 billion acquisition of and merger with Bema Gold Corporation, which included the acquisition of the Kupol and Julietta mines in Russia and spin-off of related assets, and the restructuring of a mining project finance facility for the Kupol mine.
    • Kinross Gold Corporation on its sale of its interest in Omolon Gold Mining Company and Omsukchansk Gold Mining Company in Russia.
    • OJSC Vimpel-Communications (VimpelCom) on its €341.9 million acquisition of 90% of CJSC Armenia Telephone Company (Armentel) from Hellenic Telecommunications Organization.
    • OJSC Vimpel-Communications (VimpelCom) on its acquisition of majority stakes in Sakhalin Telecom and Sakhalin Telecom Mobile.
    • OJSC Vimpel-Communications (VimpelCom) on its NYSE IPO, the first NYSE listing of shares by a Russian company since 1903.
    • Golden Telecom on its US$200 million acquisition by Golden Telecom of the alternative operator Comincom and its key subsidiary, Combellga, in a share exchange transaction with a large Norwegian telecommunications company.
    • A major multinational energy company on a strategic joint venture with an energy company in Russia.
    • A major multinational petroleum services company on numerous acquisitions in Russia Federal Express on corporate matters related to its representative office in Russia.
    • Part of the team acting for Marfin Popular Bank on its acquisition of a 50.04% stake in Rossisysky Promishlenny Bank (Rosprombank) based in Moscow for €83 million.
    • Part of the team acting for ICT Group on its sale of a strategic interest in NOMOS Bank to the Czech PPF Group.
    • OTP Bank on structuring real estate transactions in Russia.
    • Fortis Investments on the establishment of a joint venture in Russia with CIT Finance, including leading the due diligence teams in St. Petersburg and Moscow.
    • Alfa Capital Partners on its acquisition of shares in a holding company owning more than a dozen health clubs in Russia.
    • Nokian Tyres plc, the leading Nordic manufacturer of car tires, on the establishment of a greenfield tire factory to be built in the Leningrad region of the Russian Federation, as well as a joint venture with Amtel and other corporate transactions.
    • Gallaher Group on its US$390 million acquisition of the Liggett-Ducat tobacco production facility in Moscow.
    • General Motors on its US$350 million joint venture with AvtoVAZ, Russia’s largest automotive manufacturer and joint venture with Elabuga Automotive Plant in Tatarstan.
    • Polpharma, a manufacturer of drugs and active pharmaceutical ingredients (APIs) in Poland, on its acquisition of shares in the Russian pharmaceutical producer Open Joint Stock Company Akrikhin.
    • Polpharma on its proposed acquisitions of two other Russian pharmaceutical companies as well as employment matters under Russian law and intellectual property matters under Russian law.
    • Mundipharma Medical GmbH on a distribution agreement, product supply contract and delivery contract with a Russian legal entity for the provision of pharmaceutical products, establishing a representative office in Russia, and general corporate matters in Russia.
    • Lek Pharmaceuticals, a wholly owned subsidiary of Sandoz, on the establishment of a representative office in Russia, litigation related to the bankruptcy of a pharmaceutical distributor and general corporate matters in Russia.
    • Leciva A.S. (now part of Zentiva N.V., a leading international pharmaceutical company on the Czech Republic, Turkey, Romania, Poland, Slovakia and Russia) on general corporate matters and employment matters in Russia.
    • Leading foreign pharmaceutical companies on various issues associated with conducting clinical trials in Russia, including execution of clinical trial agreements with Russia-based laboratories.

     

    • Lomonosov Moscow State University
    • Leiden Law School
    • Russian Federation
    • Russian
    • English
    • Start Your Business in Russia - Key Legal Points — A presentation at the Russian-Monaco Economic Forum, hosted by the Russian Federation Chamber of Commerce and Industry, Moscow (October 5, 2016)